Ketorolac tromethamine and Pradaxa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ketorolac tromethamine (ketorolac tromethamine) and Pradaxa (dabigatran etexilate mesylate). Common drug interactions include acute myocardial infarction among females and post procedural haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Ketorolac tromethamine and Pradaxa. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Ketorolac tromethamine?

Ketorolac tromethamine has active ingredients of ketorolac tromethamine. It is often used in pain. eHealthMe is studying from 5,237 Ketorolac tromethamine users. Check the latest studies of Ketorolac tromethamine.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.



On Jul, 10, 2026

11 people who take Ketorolac tromethamine and Pradaxa together, and have interactions are studied.

Ketorolac tromethamine and Pradaxa drug interactions.

What are the common drug interactions of Ketorolac Tromethamine and Pradaxa, by gender? *:

female:

  1. Acute myocardial infarction (acute heart attack)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Ear infection
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Infection
  6. Influenza
  7. Localised infection (infection at the single location)
  8. Lower respiratory tract infection bacterial
  9. Pneumonia
  10. Respiratory tract infection

male:

  1. Post procedural haemorrhage (post procedural bleeding)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  4. Abdominal discomfort
  5. Acute myocardial infarction (acute heart attack)
  6. Gastric mucosal hypertrophy (inflammation and ulcers (breaks on the skin or on the surface of an organ) of the mucosa (inner lining) of the stomach)
  7. General physical health deterioration (weak health status)
  8. Hepatic enzyme increased
  9. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  10. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)

What are the common drug interactions of Ketorolac Tromethamine and Pradaxa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Post procedural haemorrhage (post procedural bleeding)
  2. Acute myocardial infarction (acute heart attack)
  3. Respiratory tract infection
  4. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  5. Sinusitis (inflammation of sinus)
  6. Urinary tract infection
  7. Abdominal discomfort
  8. Dyspnoea (difficult or laboured respiration)
  9. Erythema (redness of the skin)
  10. Gastric mucosal hypertrophy (inflammation and ulcers (breaks on the skin or on the surface of an organ) of the mucosa (inner lining) of the stomach)

What are the existing conditions these people have? *

  1. Gout (uric acid crystals building up in the body): 5 people, 45.45%
  2. Immunodeficiency Common Variable: 2 people, 18.18%
  3. Type 2 Diabetes: 1 person, 9.09%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 9.09%
  5. Rickets (softening of bones): 1 person, 9.09%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
  7. Renal Colic (renal pain): 1 person, 9.09%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 9.09%
  10. Back Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ketorolac tromethamine and Pradaxa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ketorolac tromethamine and Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ketorolac tromethamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ketorolac tromethamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pradaxa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine and dabigatran etexilate mesylate (the active ingredients of Ketorolac tromethamine and Pradaxa, respectively), and Ketorolac tromethamine and Pradaxa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: